May 1 (Reuters) - Consumer healthcare company Haleon's ( HLN )

first-quarter revenue missed market estimates on

Wednesday, due to retailer destocking in the U.S., and a cool

down in demand for cold and flu medication after a surge last

year.

Revenues stood at 2.92 billion pounds ($3.64 billion) for

the quarter ended March 31, slightly missing expectations of

2.93 billion pounds, according to a company-compiled consensus.

($1 = 0.8021 pounds)